Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2010
10/13/2010EP2238159A1 Novel protein
10/13/2010EP2238158A1 Novel bacillus thuringiensis gene with coleopteran activity
10/13/2010EP2238157A2 Engineered bacteriophages as adjuvants for antimicrobial agents and compositions and methods of use thereof
10/13/2010EP2238156A1 Methods to stabilize proteins and polypeptides
10/13/2010EP2238155A2 Cynomolgus toll-like receptor 3
10/13/2010EP2238153A1 Semi-recombinant preparation of glp-1 analogues
10/13/2010EP1987357B1 Polypeptides recognized by anti-trichinella antibodies, and uses thereof
10/13/2010EP1904518B1 Dna polymerase blends and mutant dna polymerases
10/13/2010EP1694852B1 Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer
10/13/2010EP1675956B1 Minimal dna sequence acting as a chromatin insulator and its use in protein expression
10/13/2010EP1633779B1 Oxidoreductase from pichia capsulata
10/13/2010EP1503785B1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
10/13/2010EP1102848B1 Molecules designated ldcam
10/13/2010EP1005526B1 Direct expression of peptides into culture media
10/13/2010EP0942971B1 Method for altering the nutritional content of plant seed
10/13/2010CN1919869B CYP3A4 polypeptide
10/13/2010CN1896100B Liver regenerated factor and its use
10/13/2010CN1864068B Methods for reducing complexity of a sample using small epitope antibodies
10/13/2010CN1737147B Heat shock protein 65- multiple epitope hepatitis B virus core antigen recombinant protein (HSP65-HBcAg)
10/13/2010CN101861521A High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest
10/13/2010CN101861393A Plants with increased yield
10/13/2010CN101861388A Hybrid alpha-glucoside transporter
10/13/2010CN101861335A Manufacture, compositions and uses of coagulationfactor VIIA modulator
10/13/2010CN101861334A Cyclic receptor-associated protein (RAP) peptides
10/13/2010CN101861333A Pharmaceutical compositions comprising GLP-1 peptides or exendin-4 and a basal insulin peptide
10/13/2010CN101861332A Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast
10/13/2010CN101861331A Hypoallergenic variants of the major allergen from betula verrucosa pollen
10/13/2010CN101861329A Peptides as antimicrobial agents towards campylobacter spp
10/13/2010CN101861160A Antagonists of kisspeptin and uses thereof
10/13/2010CN101858911A Method for simultaneously detecting antigen and antibody of infectious microorganism
10/13/2010CN101857876A Method for producing human serum albumin from animal blood
10/13/2010CN101857871A Method for purifying recombinant VP1 antigen of enterovirus type 71 viruses
10/13/2010CN101857870A HPV58 L1 gene, vector, strain and expression method
10/13/2010CN101857868A Expression and function identification of cotton fiber development related gene 14-3-3f
10/13/2010CN101857867A Expression in filamentous fungi of protease inhibitors and variants thereof
10/13/2010CN101857851A Mammalian cell culture processes for protein production
10/13/2010CN101857635A Continuous separation method for three proteins in bovine plasma
10/13/2010CN101857634A Activator protein for fibrinolytic system
10/13/2010CN101857633A Leaf-shaped control gene SRNL1 of rice and application thereof
10/13/2010CN101857320A Method for treatment of silk degumming wastewater and recovery of silk gum
10/13/2010CN101856502A Radiolabelled insulin
10/13/2010CN101348522B Copper resistance binary signal conducting system regulation factor mutant, and construction and use thereof
10/13/2010CN101319224B Recombinant expression vector of excretion exudation protein of lung fluke, engineering bacterium, preparation method and uses thereof
10/13/2010CN101220090B Multi-modification derivant of glutin and crosslinked material thereof
10/13/2010CN101125882B Recombination PAC1 receptor agonist RMMAX and its expression method and application
10/13/2010CN101054413B Tumor correlated albumen, coding gene and application thereof
10/12/2010US7812224 Genetic engineereed herbicide; controlling weeds
10/12/2010US7812218 for improving fiber quality and/or yield of a fiber producing plant, as well as methods of using such polynucleotides for producing plants having increased biomass/vigor/yield
10/12/2010US7812215 Methods and protein production using ovomucoid promoters
10/12/2010US7812147 nucleic acid that encodes a Lactoferrin binding protein; for use in diagnosis, treatment and prevention of streptococcal pathogen infection; strep throat, scarlet fever, and rheumatic fever; mastitis
10/12/2010US7812146 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
10/12/2010US7812138 Fractionation of protein containing mixtures
10/12/2010US7812137 Identification and characterization of the receptor for leptin, including a naturally occurring soluble form; used in gene therapy or in soluble form as an agonist or antagonist of leptin activity, or diagnostically; obesity, diabetes, high blood pressure, and cholesterol
10/12/2010US7812131 protein that potentiates toxin activity of a Class A toxin complex protein against an insect; insecticides
10/12/2010US7812130 fusion protein comprising an isolated soluble cytokine receptor polypeptide; use in treatment of cell proliferative, inflammatory and immune disorders
10/12/2010US7812129 Unique novel Bacillus thuringiensis gene with lepidopteran activity
10/12/2010US7812128 protein encoded by the nucleotide sequence represented by SEQ ID NO: 15; useful for diagnosing and treating cancer
10/12/2010US7812127 Glycosylated with galactose-N-acetylgalactosamine; used for the introduction of exogenous nucleic acid sequences into the genome of avians in order to express the exogenous sequences to alter the phenotype of the avians or to produce desired proteins
10/12/2010US7812126 DNAX interferon-like receptor polypeptides for generating atibodies for use in treatment and prevention of septic shock, inflammation, cell proliferative and viral infection
10/12/2010US7812125 Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
10/12/2010US7812124 Diagnosis of tumors in humans; obtain sample tissue, extract nucleotide sequences, expose to tumor preferential marker, detect signal, signal form sample indicates tumors
10/12/2010US7812123 Alzheimer's disease secretase
10/12/2010US7812122 Protein sweetener
10/12/2010US7812119 interfacial biomaterial (IFBM); coating to promote osteointegration of the implant, accelerating healing; includes peptide that binds to the surface of the implant, and to e.g. bone morphogenic proteins
10/12/2010US7812117 stimulating the proliferation or survival of a hematopoietic cell exposed to a chemotherapeutic agent or irradiation; fusion polypeptide
10/12/2010US7812116 Immunogenic peptides
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7811992 Measuring binding of Bradykinin and angiogensin receptor; calibration; animal hibernation
10/12/2010US7811991 Polypeptide therapeutic for treating ischemia associated with perioperative surgical procedure
10/12/2010US7811990 Using tumor necrosis factor modulators/inhibitors as tool in treatment and prevention of spinal cord injury
10/12/2010US7811989 Peptide YY analogs
10/12/2010US7811986 Testing by immunoassay for overexpression which is an indicator of breast cancer; relates to cDNA sequences from a region of amplification on chromosome 20 associated with disease. used in hybridization methods for the identification of chromosomal abnormalities
10/12/2010US7811985 Treatment and prophylaxis of reperfusion injuries, particularly after cardiac necrosis; administering an N-terminus modified polypeptide derived from the A alpha chain of fibrinand the B beta chain of fibrin; antiinflammatory agents
10/12/2010US7811984 BV8 nucleic acids and polypeptides with mitogenic activity
10/12/2010US7811812 For use in gene therapy and recombinant protein production
10/12/2010US7811793 Using trangenic escherichia to generate bone morphogenic protein for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
10/12/2010US7811791 nucleic acid ; for diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IFN-L polypeptides
10/12/2010US7811789 Expression vector comprising nucleotide sequences coding migration stimulation factor for use in identifying modulator for treatment and prevention of cell proliferative disorders; wound healing agents
10/12/2010US7811785 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation
10/12/2010US7811777 for treatment of disorders which are mediated at least in part by Hedgehog (Hh) especially Desert hedgehog (Dhh) in particular testicular cancer
10/12/2010US7811770 Method of detecting a subfraction of proBNP
10/12/2010US7811769 Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
10/12/2010US7811592 For immunizing an animal
10/12/2010US7811591 comprising non-typeable H. influenzae (NTHi) twitching pilus major subunit protein; otitis media, pneumonia, sinusitis, septicemia, endocarditis, epiglottitis, septic arthritis, meningitis, sepsis, salpingitis, epiglottis, pericardis, cellulitis, osteomyelitis, endocarditis, cholecystitis
10/12/2010US7811590 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system
10/12/2010US7811588 Therapeutic agent for treatment and prevention of bacterial infections; immunoassay
10/12/2010US7811585 Streptococcus pyogenes antigens
10/12/2010US7811581 immunogens; tumor antigens; devoid of immunosuppressive domain; fusion proteins; immunotherapy
10/12/2010US7811580 Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes
10/12/2010US7811579 Full-length genomic RNA of Japanese encephalitis virus, infectious JEV cDNA therefrom, and use thereof
10/12/2010US7811578 Soluble chimeric peptide inhibitors of HIV entry comprising an IZ trimeric coiled-coil peptide and HIV gp41 N-helix coiled-coil peptide
10/12/2010US7811577 Covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity
10/12/2010US7811576 Composition comprising hepadnavirus core antigen for use in preparing vaccines against hepatitis infection
10/12/2010US7811575 Diagnosis by detecting overexpression; active or passive immunization; antibodies, transgenic animals, hybridoma
10/12/2010US7811574 prophylaxis and diagnosis of neoplastic growth by administering polypeptides and polynucleotides, variants, fragments and fusion proteins, to induce immunogenic response tumor antigens; immunology
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010US7811566 Antibody-induced apoptosis
10/12/2010US7811564 antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis; prostate specific membrane antigen (PSMA)
10/12/2010US7811561 MCT-1, a human oncogene
10/12/2010US7811559 Administering to the patient an amount of CLN2 protein (Neuronal ceroid lipofuscinoses (NCLs)) effective to reduce or eliminate the symptoms caused by the deficiencyl in CLN2 protein; Central nervous system disorders